ArticleThoracic cancer2022

E2112-Does a negative phase III trial of endocrine therapy plus histone deacetylase inhibitor in hormone receptor-positive advanced breast cancer represent a death knell?

Liyi ZhangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.